Dermatol. praxi. 2022;16(1):17-21 | DOI: 10.36290/der.2022.003

Dermatoses in pregnancy

MUDr. Filip Rob, Ph.D.
Dermatovenerologická klinika 2. LF UK a Fakultní nemocnice Bulovka, Praha

During pregnancy physiological and pathological changes occur due to hormonal and immunological changes. Most of these changes are benign in nature and do not endanger the mother or the fetus, however, they can have a significant impact on a woman's quality of life during pregnancy. Moreover due to the potential teratogenic or toxic effect of some drugs, therapeutic options may be limited in some cases. Pregnancy dermatoses form a separate group of diseases, which include gestational pemphigoid, intrahepatic cholestasis in pregnancy, atopic eruptions in pregnancy, and polymorphic eruptions in pregnancy. Recognizing them can sometimes be difficult, thus proper diagnosis is very important.

Keywords: gestational pemphigoid, polymorphic eruption of pregnancy, atopic eruption of pregnancy, intrahepatic cholestasis of pregnancy.

Published: April 4, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rob F. Dermatoses in pregnancy. Dermatol. praxi. 2022;16(1):17-21. doi: 10.36290/der.2022.003.
Download citation

References

  1. Ciechanowicz P, Sikora M, Taradaj K, et al. Skin changes during pregnancy. Is that an important issue for pregnant women? Ginek polska. 2018;89(8):450-453. Go to original source... Go to PubMed...
  2. Ambros-Rudolph CM, Mullegger RR, Vaughan-Jones SA, et al. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol. 2006;54:395-404. Go to original source... Go to PubMed...
  3. Pemphigoid (herpes) gestationis. In: Black MM, et al. Obstetric and gynecologic dermatology. 3rd ed. London: Elsevier Limited; 2008. p. 37-47. Go to original source...
  4. Shornick JK, Black MM. Secondary autoimmune diseases in herpes gestationis (pemphigoid gestationis). J Am Acad Dermatol. 1992;26(4):563-566. Go to original source... Go to PubMed...
  5. Zilikens D. Pemphigoid gestationis: recent advances. J Eur Acad Dermatol. 2003;17:7.
  6. Ortonne JP, Hsi BL, Verrando P, et al. Herpes gestationis factor reacts with the amniotic epithelial basement membrane. Br J Dermatol. 1987;117(2):147-154. Go to original source... Go to PubMed...
  7. Semkova K, Black M, et al. Pemphigoid gestationis: current insights into pathogenesis and treatment. Eur J Obstet Gynecol Reprod Biol. 2009;145(2):138-144. Go to original source... Go to PubMed...
  8. Genovese G, Derlino F, Cerri A, et al. A systematic review of treatment options and clinical outcomes in pemphigoid gestationis. Front Med. 2020;7:110-116. Go to original source... Go to PubMed...
  9. Chi CC, Wang SH, Charles-Holmes R, et al. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol. 2009;160(6):1222-1228. Go to original source... Go to PubMed...
  10. Rudolph CM, Al-Fares S, Vaughan-Jones SA, et al. Polymorphic eruption of pregnancy: clinicopathology and potential trigger factors in 181 patients. Br J Dermatol. 2006;154(1):54-60. Go to original source... Go to PubMed...
  11. Brandão P, Sousa-Faria B, Marinho C, et al. Polymorphic eruption of pregnancy: review of literature. J Obstet Gynaecol. 2017;37(2):137-140.
  12. García-González E, Ahued-Ahued R, Arroyo E, et al. Immunology of the cutaneous disorders of pregnancy. Int J Dermatol. 1999;38(10):721-729. Go to original source... Go to PubMed...
  13. Ambros-Rudolph, CM. Dermatoses of pregnancy - clues to diagnosis, fetal risk and therapy. Ann Dermatol. 2011;23(3):265-275. Go to original source... Go to PubMed...
  14. Abedin PB, Weaver J, Egginton E. Intrahepatic cholestasis of pregnancy: Prevalence and ethnic distribution. Ethn Health. 1999;4(1-2):35-37. Go to original source... Go to PubMed...
  15. Marschall HU, Wilkstrom Shemer E, Ludvigsson JF, et al. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: A population-based cohort study. Hepatol. 2013;58(4):1385-1391. Go to original source... Go to PubMed...
  16. Ropponen A, Sund R, Riikonen S, et al. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology. 2006;43(4):723-728. Go to original source... Go to PubMed...
  17. Dixon PH, Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol. 2016;40(2):141-153. Go to original source... Go to PubMed...
  18. Kenyon AP, Tribe RM, Nelson-Percy C, et al. Pruritus in pregnancy: A study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis. Obstet Med. 2010;3(1):25-29. Go to original source... Go to PubMed...
  19. DeLeon A, De Oliveira GS, Kalayil M, et al. The incidence of coagulopathy in pregnant patients with intrahepatic cholestasis: Should we delay or avoid neuraxial analgesia? J Clin Anesth. 2014;26(8):623-627. Go to original source... Go to PubMed...
  20. Geenes V, Chappell LC, Seed PT, et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: A prospective population-based case-control study. Hepatology. 2014;59(4):1482-1491. Go to original source... Go to PubMed...
  21. Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174):899-909. Go to original source... Go to PubMed...
  22. Wikstrom Shemer EA, Stephansson O, Thuresson M, et al. Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: A population-based cohort study. J Hepatol. 2015;63(2):456-461. Go to original source... Go to PubMed...
  23. Smith DD, Rood KM. Intrahepatic cholestasis of pregnancy. Clin Obstet Gynecol. 2020;63(1):134-151. Go to original source... Go to PubMed...
  24. Grand'Maison S, Durand M, Mahone M. The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: A meta-analysis including non-randomized studies. J Obstet Gynaecol Can. 2014;36(7):632-641. Go to original source... Go to PubMed...
  25. Ovadia C, Williamson C, et al. Intrahepatic cholestasis of pregnancy: recent advances. Clin Dermatol. May-June 2016;34(3):327-334. Go to original source... Go to PubMed...
  26. Lo JO, Shaffer BF, Allen AJ, et al. Intrahepatic cholestasis of pregnancy and timing of delivery. J Matern Fetal Neonatal Med. 2015;28(18):2254-2258. Go to original source... Go to PubMed...
  27. Chang SE, Kim HH, Choi JH, et al. Impetigo herpetiformis followed by generalized pustular psoriasis: more evidence of same disease entity. Int J Dermatol. 2003;42(9):754-755.
  28. Košťálová M. Kožní choroby v těhotenství - II. Část. Dermatol. praxi 2009;3(1):23-28.
  29. Namazi N, Dadkhahfar S. Impetigo herpetiformis: review of pathogenesis, complication, and treatment. Derm Res Pract. 2018;2018:5801280. Go to original source... Go to PubMed...
  30. Chien AL, Qi J, Rainer B, et al. Treatment of acne in pregnancy. J Am Board Famil Medic. 2016;29(2):254-262. Go to original source... Go to PubMed...
  31. Romoren M, Lindbaek M, Nordeng H. Pregnancy outcome after gestational exposure to erythromycin-a population-based register study from Norway. Br J Clin Pharmacol. 2012;74(6):1053-1062. Go to original source... Go to PubMed...
  32. Muzaffar F, Haroon TS. Physiologic skin changes during pregnancy: a study of 140 cases. Int J Dermatol. 1998;37(6):429-431. Go to original source... Go to PubMed...
  33. Kroumpouzos G. Dermatoses of pregnancy. J Am Acad Dermatol. 2001;45:1-22. Go to original source... Go to PubMed...
  34. Al-Himdani S, Ud-Din S, Gilmore S, et al. Striae distensae: a comprehensive review and evidence-based evaluation of prophylaxis and treatment. Br J Dermatol. 2014;170(3):527-547. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.